Tandem Diabetes Care (TNDM) Current Assets (2013 - 2026)

Tandem Diabetes Care's Current Assets history runs 14 years deep, the most recent figure standing at $887.1 million for Q1 2026.

• Quarterly Current Assets rose 33.71% year-over-year to $887.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $887.1 million (up 33.71% YoY) and the FY2025 annual result came in at $618.1 million, down 14.68% from the prior year.
• Current Assets was $887.1 million for Q1 2026 at Tandem Diabetes Care, up from $618.1 million in the prior quarter.
• Across five years, Current Assets topped out at $887.1 million in Q1 2026 and bottomed at $614.8 million in Q2 2025.
• A 5-year average of $747.8 million and a median of $752.8 million in 2024 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2025 — Current Assets slipped 18.05% — and 2026, when it soared 33.71%.
• Tandem Diabetes Care's Current Assets stood at $850.0 million in 2022, then retreated by 12.0% to $748.0 million in 2023, then slipped by 3.14% to $724.5 million in 2024, then slipped by 14.68% to $618.1 million in 2025, then jumped by 43.51% to $887.1 million in 2026.
• Business Quant data shows TNDM's Current Assets at $887.1 million in Q1 2026, $618.1 million in Q4 2025, and $616.9 million in Q3 2025.